Heterologous interference between Mayaro and Chikungunya viruses in Vero cells

Mauricio Gabriel E L Silva1, Karla Fabiane L Melo2, Samir M M Casseb2

  • 1Center for Biological and Health Sciences, University of Pará State, Travessa Perebebuí, 2623 - Marco, Belém, PA, Brazil, 66095-662; Section for Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Rodovia BR-316, km 7 s/n - Levilândia, Ananindeua, PA, Brazil, 67030-000.

Abstract

Insights

Mayaro virus (MAYV) and Chikungunya virus (CHIKV) coinfections and superinfections in primate cells show significant heterologous interference, reducing viral loads by over 90%. This interaction may influence disease outcomes in humans.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Mayaro virus (MAYV) and Chikungunya virus (CHIKV) are arthritogenic alphaviruses co-circulating in Central and South America.
  • Their shared vertebrate hosts create opportunities for human coinfections and superinfections.

Purpose of the Study:

  • To investigate heterologous viral interference between MAYV and CHIKV during coinfections and superinfections.
  • To analyze the impact of these interactions in a primate cell line model.

Main Methods:

  • Experimental infections with MAYV and CHIKV were performed singly, simultaneously, or consecutively.
  • Cytopathic effect, cell viability, and virus load were assessed using microscopy, fluorimetry, and RT-qPCR.

Main Results:

  • All infection schemes caused significant cytopathic effects and reduced cell viability by ~90% within 24 hours.
  • Coinfections showed no significant difference in viral loads but reduced individual virus loads by over 90% compared to single infections.
  • Superinfections demonstrated a 'first-mover advantage,' significantly altering progeny virus formation regardless of the specific virus.

Conclusions:

  • MAYV and CHIKV exhibit heterologous interference during coinfection and superinfection in primate cells.
  • This interference mechanism could potentially affect disease progression and outcomes in human infections.